As expression of TLK1 and TLK2 exhibited significantly different patterns across cancer types, this emphasizes the need to consider the distinct genetic statuses and activities of TLK1 and TLK2 based on the cancer subtype for their application in therapeutic strategies. This evidence concerns the gene TLK1 and cancer.